US Patent 12128140 Extended release pharmaceutical formulation

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121281400

Patent Inventor Names

Paul William Glue0

Peter William Surman0

Natalie June Medlicott0

Date of Patent

October 29, 2024

Patent Application Number

174422390

Date Filed

March 5, 2020

Patent Citations

‌

US Patent 8114383 Abuse-proofed dosage form

‌

US Patent 8137711 Methods of treating neuropathy

‌

US Patent 8309060 Abuse-proofed dosage form

‌

US Patent 9272037 Method to treat premature ejaculation in humans

‌

US Patent 9533982 Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators

‌

US Patent 9650362 Inhibitors

‌

US Patent 9867830 Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

‌

US Patent 10441544 Extended release pharmaceutical formulation

...

Patent Primary Examiner

‌

Aradhana Sasan

Patent abstract

The disclosure provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12128140 Extended release pharmaceutical formulation

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12128140 Extended release pharmaceutical formulation